Procore Technologies Inc SEC Filings

Procore Technologies (PCOR) reported an insider transaction: a director filed a Form 4 showing open‑market sales of common stock executed under a Rule 10b5‑1 plan dated November 21, 2024.

On October 14–15, 2025, the reported sales were: 4,984 shares at a weighted average price of $70.25; 2,708 shares at $71.14; 5,574 shares at $72.36; and 2,118 shares at $72.91. The filing notes the weighted average prices reflect trades within specified ranges.

After these transactions, 1,107,945 shares of common stock were beneficially owned indirectly by the Kevin J. O'Connor Revocable Trust.

PROCORE TECHNOLOGIES insider sale by CFO. The filing shows CFO & Treasurer Howard Fu reported the sale of 796 shares of Procore Technologies common stock on 09/22/2025 at a price of $71.02 per share under a pre-established 10b5-1 plan dated 11/15/2024. After the reported sale, Mr. Fu beneficially owns 188,661 shares, held directly. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/24/2025. The filing is a routine Section 16 disclosure of an insider sale executed via a trading plan.

Benjamin C. Singer, Chief Legal Officer and Secretary of Procore Technologies, sold 1,036 shares of Procore common stock on 09/23/2025 at a price of $75 per share. After this transaction he beneficially owned 85,330 shares. The sale was executed pursuant to a 10b5-1 plan dated August 15, 2024, and the Form 4 was signed on 09/24/2025.

The filing reports a single non-derivative disposition and does not disclose any other purchases, derivative transactions, or changes in indirect ownership. The Form 4 indicates the reporting person filed individually and identifies his relationship to the issuer as an officer and director.

Form 144 filing for Procore Technologies, Inc. (PCOR) notifies the proposed sale of 1,036 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $77,700.00, with an approximate sale date of 09/23/2025. The shares were acquired as restricted stock from the issuer on 08/20/2024. The filer certifies no undisclosed material adverse information and the filing lists recent sales by Benjamin C. Singer totaling 10,095 shares sold on 07/10/2025, 07/21/2025 and 08/21/2025 for aggregate gross proceeds of $709,465.95. The notice provides broker details and confirms the nature and timing of acquisition and previous sales.

Procore Technologies (PCOR) Form 4: The filing reports that Gopal Ajei, listed as a director and "CEO Designate," acquired 409,283 shares of common stock on 09/22/2025 via the settlement of restricted stock units (RSUs) at a $0 purchase price. After the transaction he beneficially owns 409,283 shares directly. The RSUs vest according to the grant agreement: one-fourth vests on the first anniversary of the Vesting Commencement Date, then one-sixteenth vests quarterly on each February 20, May 20, August 20 and November 20, subject to continued service through each vesting date. The form is signed by an attorney-in-fact on 09/22/2025.

Gopal Ajei filed an initial Form 3 on 09/22/2025 reporting his relationship with Procore Technologies, Inc. (PCOR) as a Director and CEO Designate. The filing shows zero shares of common stock beneficially owned and no derivative securities reported. The form was signed by an attorney-in-fact on behalf of the reporting person.

Procore Technologies disclosed the employment terms for Ajei S. Gopal as its new President and Chief Executive Officer. The company will pay an annual base salary of $750,000 and a target annual bonus equal to 150% of base salary with up to 200% of target payable based on company performance. He will receive a one-time $320,000 sign-on bonus, reimbursement of up to $125,000 for legal fees, and an RSU grant priced using the 30-trading-day VWAP ending September 18, 2025, that vests over four years with full vesting on death or permanent disability.

Severance provides 18 months of salary and target bonus for termination without cause (24 months if tied to a change in control), COBRA premium payments, and accelerated vesting of time-based equity under specified circumstances.

Procore Technologies (PCOR) Form 144 notice reports proposed and recent sales of common stock by an individual. The filing shows a proposed sale of 796 common shares through Morgan Stanley Smith Barney LLC on 09/22/2025 with an aggregate market value of $56,531.92 and 150,192,801 shares outstanding. The 796 shares were acquired as restricted stock on 08/20/2025 from the issuer, with payment noted as not applicable. The filing also discloses two prior sales by the same person: 797 shares sold 08/21/2025 for $50,888.45 and 814 shares sold 07/21/2025 for $60,520.90. The seller is identified as Howard Fu with a Carpinteria, CA address. The notice includes the standard representation that the signer is not aware of undisclosed material adverse information.

Kevin J. O'Connor, a director of Procore Technologies (PCOR), reported scheduled sales of company stock under a prearranged 10b5-1 plan. The filings show dispositions on 09/16/2025 and 09/17/2025: 7,692 shares sold at a weighted average price of $70.41 (range $70.05–$70.85), 7,255 shares sold at $72.55 (range $71.80–$72.775), and 437 shares sold at $72.93 (range $72.905–$72.955).

Following the transactions the filing reports indirect beneficial ownership maintained in the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19, with reported holdings of 1,131,021, then 1,123,766, then 1,123,329 shares after each sale. The Form 4 was signed by attorney-in-fact Benjamin C. Singer on 09/18/2025.